![Michael Porter](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Michael Porter is the founder of Covis Group SARL, established in 2011, where the title held was Chief Executive Officer & Director.
Current jobs include Chief Executive Officer at Covis Pharma US, Inc.; Chief Executive Officer at Covis Group SARL (New Jersey) since 2015; President & Director at AMAG Pharma USA, Inc.; Director at Huxley Medical, Inc. since 2021; Director at Pressio Spine since 2021; President & Director at AMAG Pharmaceuticals, Inc.; Independent Director at Freedom Metals Acquisition Corp.; and Director at restor3d, Inc. since 2023.
Former jobs include Chief Executive Officer at Covis Pharma Holdings BV; Chairman-Managers Board at Ciraparantag Holdings GmbH from 2022 to 2025; and Chief Operating & Financial Officer at Covis Pharma Holdings SARL. Education includes undergraduate studies at the University of Illinois At Urbana–Champaign and an MBA from Columbia Business School.
| Sociétés | Poste | Début |
|---|---|---|
| AMAG PHARMACEUTICALS, INC. | President | - |
AMAG Pharma USA, Inc.
 AMAG Pharma USA, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Directeur Général | - |
Covis Pharma Us, Inc.
 Covis Pharma Us, Inc. Aerospace & DefenseElectronic Technology The private company is based in King of Prussia, PA. Covis Pharma US, Inc. focuses on marketing and developing therapeutic solutions for patients with life-threatening and chronic illnesses across more than 50 countries. The company offers a portfolio of affordable, therapeutically equivalent branded medications spanning respiratory, allergy, hematology, cardiovascular, and gastroenterology areas, with key products including Alvesco®, Duaklir®, Tudorza®, Feraheme®, Lanoxin®, Altoprev®, Sular®, and Prilosec®. Covis Pharma US has grown through strategic acquisitions and partnerships with leading pharmaceutical firms and contract manufacturers to ensure supply chain security and product quality. The company provides medical information, patient assistance programs, and supports educational initiatives and investigator-sponsored research, particularly in respiratory and diagnostic imaging fields. It maintains compliance with regulations, offering detailed prescribing and safety information for healthcare professionals and patients. Covis Pharma US is now part of Azurity Pharmaceuticals. The CEO of the company is Michael Porter. | Directeur Général | - |
Huxley Medical, Inc.
 Huxley Medical, Inc. Medical SpecialtiesHealth Technology Manufactures cardio sleep diagnosis monitoring devices | Directeur/Membre du Conseil | 01/01/2021 |
restor3d, Inc.
 restor3d, Inc. Medical SpecialtiesHealth Technology Manufactures and sells 3D printed orthopedic medical devices | Directeur/Membre du Conseil | 01/01/2023 |
| Sociétés | Poste | Fin |
|---|---|---|
Covis Group SARL
 Covis Group SARL Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company for therapeutic solutions for patients with life-threatening conditions and chronic illnesses | Fondateur | 01/01/2025 |
Covis Pharma Holdings BV
 Covis Pharma Holdings BV Pharmaceuticals: MajorHealth Technology Engages in the manufacturing and distribution of specialty pharmaceuticals | Directeur Général | 26/06/2023 |
Covis Pharma Holdings SARL
 Covis Pharma Holdings SARL Financial ConglomeratesFinance Operates as a holding company with interests in manufacturing and distribution of specialty pharmaceuticals | Directeur Général | 01/01/2015 |
Actives
Inactives
Sociétés cotées
Entreprise privées
| Entreprise privées | 10 |
|---|---|
AMAG Pharma USA, Inc.
AMAG Pharma USA, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
AMAG Pharmaceuticals, Inc.
 AMAG Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Covis Pharma Holdings BV
Covis Pharma Holdings BV Pharmaceuticals: MajorHealth Technology Engages in the manufacturing and distribution of specialty pharmaceuticals | Health Technology |
Covis Pharma Holdings SARL
Covis Pharma Holdings SARL Financial ConglomeratesFinance Operates as a holding company with interests in manufacturing and distribution of specialty pharmaceuticals | Finance |
Columbia Business School
 Columbia Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
restor3d, Inc.
restor3d, Inc. Medical SpecialtiesHealth Technology Manufactures and sells 3D printed orthopedic medical devices | Health Technology |
University of Illinois At Urbana–Champaign
 University of Illinois At Urbana–Champaign Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Covis Group SARL
Covis Group SARL Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company for therapeutic solutions for patients with life-threatening conditions and chronic illnesses | Health Technology |
Huxley Medical, Inc.
Huxley Medical, Inc. Medical SpecialtiesHealth Technology Manufactures cardio sleep diagnosis monitoring devices | Health Technology |
Covis Pharma Us, Inc.
Covis Pharma Us, Inc. Aerospace & DefenseElectronic Technology The private company is based in King of Prussia, PA. Covis Pharma US, Inc. focuses on marketing and developing therapeutic solutions for patients with life-threatening and chronic illnesses across more than 50 countries. The company offers a portfolio of affordable, therapeutically equivalent branded medications spanning respiratory, allergy, hematology, cardiovascular, and gastroenterology areas, with key products including Alvesco®, Duaklir®, Tudorza®, Feraheme®, Lanoxin®, Altoprev®, Sular®, and Prilosec®. Covis Pharma US has grown through strategic acquisitions and partnerships with leading pharmaceutical firms and contract manufacturers to ensure supply chain security and product quality. The company provides medical information, patient assistance programs, and supports educational initiatives and investigator-sponsored research, particularly in respiratory and diagnostic imaging fields. It maintains compliance with regulations, offering detailed prescribing and safety information for healthcare professionals and patients. Covis Pharma US is now part of Azurity Pharmaceuticals. The CEO of the company is Michael Porter. | Electronic Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national
